Glycerol phenylbutyrate and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Glycerol phenylbutyrate and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycerol phenylbutyrate-Insulin degludec Subcutaneous
- Glycerol phenylbutyrate-Insulin detemir
- Glycerol phenylbutyrate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Glycerol phenylbutyrate-Insulin Detemir (Vials)
- Glycerol phenylbutyrate-Insulin detemir Subcutaneous
- Glycerol phenylbutyrate-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-GlycoLax
- Insulin degludec and liraglutide Subcutaneous-Glycophos
- Insulin degludec and liraglutide Subcutaneous-Glycophos Injection
- Insulin degludec and liraglutide Subcutaneous-Glycopyrrolate
- Insulin degludec and liraglutide Subcutaneous-Glycopyrrolate (Oral Inhalation)
- Insulin degludec and liraglutide Subcutaneous-Glycopyrrolate (Systemic)